Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Tianyin Pharmaceutical reports 40.2% increase in revenues for the first quarter of fiscal 2010

Tianyin Pharmaceutical Co., Inc., a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced fiscal results for its first quarter ended September 30, 2009.

13 Nov 2009

Ore Pharmaceutical Holdings reports financial results and provides operational updates for third quarter 2009

Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.

13 Nov 2009

Kun Run Biotechnology net revenue increases 65% for the quarter ended September 30, 2009

Kun Run Biotechnology, Inc., a leading bio-pharmaceutical company in China that focuses on manufacturing and sales of peptides and peptide-based drugs, today announced its financial results for the third quarter ended September 30, 2009.

13 Nov 2009

Agilent Technologies reports decreased revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009

Agilent Technologies Inc. today reported revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009, 21 percent below one year ago. Fourth quarter GAAP net income was $25 million, or $0.07 per diluted share. Last year’s fourth quarter GAAP net income was $231 million, or $0.64 per share.

13 Nov 2009

Emergent BioSolutions acquires 55,000 square foot manufacturing facility from MdBio Foundation

Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million. The facility, located within the City of Baltimore, Maryland, previously operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.

13 Nov 2009

Third quarter 2009 financial results announced by Soligenix

Soligenix, Inc., (Soligenix or the Company) (OTC Bulletin Board: SNGX), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today its financial results for the third quarter of 2009.

13 Nov 2009

BSI implements plans to expand its medical device Notified Body scope to include IVD devices

BSI, a world-class Notified Body providing regulatory and quality management reviews and product certification for medical devices, is rapidly implementing plans to expand its medical device Notified Body scope to include in vitro diagnostic (IVD) devices.

13 Nov 2009

Transcept Pharmaceuticals reports financial results for the third quarter of 2009

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the three and nine months ended September 30, 2009.

13 Nov 2009

CDC expected to revise estimated number of U.S. H1N1 deaths

Ahead of the anticipated CDC release of revised U.S. H1N1 (swine flu) death toll estimates, Reuters examines how the agency and WHO measure the impact of the virus, after both organizations "stopped trying to count actual cases months ago, once it became clear that H1N1 was a pandemic that would infect millions."

12 Nov 2009

The Quigley Corporation announces financial results for the third quarter of 2009

The Quigley Corporation, today reported net sales of $5.0 million for the three months ended September 30, 2009, compared to net sales of $6.4 million for the three months ended September 30, 2008.

12 Nov 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.

12 Nov 2009

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

Bradmer Pharmaceuticals Inc. today announced its 2009 third quarter financial results.

12 Nov 2009

ADOA praises APHA for passing landmark Elimination of Asbestos Resolution

The Asbestos Disease Awareness Organization (ADAO) applauds the American Public Health Association (APHA), the largest and most diverse public health organization in the world.

12 Nov 2009

Pacific Biosciences selects Camstar Manufacturing enterprise software to deliver innovative products

Camstar Systems, Inc. announced today that Pacific Biosciences, a leader in the development of a transformative Single Molecule Real Time (SMRT™) DNA sequencing platform, has selected the Camstar Manufacturing™ enterprise software platform to enable its critical transition from product development to high-volume production, and to ensure consistent top product quality.

12 Nov 2009

Nutri-Force Nutrition completes new manufacturing facility in Miami Lakes, Florida

Nutri-Force Nutrition is proud to announce the completion of its innovative new manufacturing facility in Miami Lakes, Florida. This new facility was designed from the ground up to provide Nutri-Force's highly-valued customers with industry-leading quality and exceptionally efficient manufacturing resources.

11 Nov 2009

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States

11 Nov 2009

Duke University, Jubilant Organosys sign letter of intent for drug development partnership

Duke University and Jubilant Organosys Limited, the largest integrated Custom Research and Manufacturing Services (CRAMS) and leading Drug Discovery and Development Services (DDDS) company in India, through its subsidiary, Jubilant Biosys Limited, today signed a Letter of Intent to develop a multi-faceted partnership that will expedite translation of discoveries by Duke scientists into clinical therapies.

11 Nov 2009

Manufacturing News and Research

Further Reading

Tianyin Pharmaceutical reports 40.2% increase in revenues for the first quarter of fiscal 2010

Ore Pharmaceutical Holdings reports financial results and provides operational updates for third quarter 2009

Kun Run Biotechnology net revenue increases 65% for the quarter ended September 30, 2009

Agilent Technologies reports decreased revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009

Emergent BioSolutions acquires 55,000 square foot manufacturing facility from MdBio Foundation

Third quarter 2009 financial results announced by Soligenix

BSI implements plans to expand its medical device Notified Body scope to include IVD devices

Transcept Pharmaceuticals reports financial results for the third quarter of 2009

CDC expected to revise estimated number of U.S. H1N1 deaths

The Quigley Corporation announces financial results for the third quarter of 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

ADOA praises APHA for passing landmark Elimination of Asbestos Resolution

Pacific Biosciences selects Camstar Manufacturing enterprise software to deliver innovative products

Nutri-Force Nutrition completes new manufacturing facility in Miami Lakes, Florida

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

Duke University, Jubilant Organosys sign letter of intent for drug development partnership

FDA Commissioner thanks America's doctors for their efforts during 2009 H1N1 influenza outbreak

First human study to measure effects of BPA on male reproductive system

Particle Sciences expands operations by acquiring new additional space

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News